Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.3300 (4.29%) ($15.3300 - $15.3300) on Mon. Jan. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.16% (three month average) | RSI | 48 | Latest Price | $15.3300(4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(51%) IBB(48%) ARKG(47%) ARKK(47%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.08% in a week (0% probabilities). VIXM(-42%) VXX(-31%) UNG(-18%) USO(-15%) UUP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.08% (StdDev 4.16%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.93(2.68%) | 10 Day Moving Average | $14.78(3.72%) | 20 Day Moving Average | $15.18(0.99%) | To recent high | -22.9% | To recent low | 9.6% | Market Cap | $1.139b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |